INP-102

N/A

Report date: 2022/06/27 20:00:35
NME

Base Information

Drug NameINP-102
Drug Alias NameInsulin(Impel Pharmaceuticals)POD™ insulinINP-102
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionPhosphokinases stimulantsOrnithine decarboxylase stimulants
TargetsPhosphokinasesOrnithine decarboxylase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued
Highest Status in ChinaN/A
Originator CompaniesImpel Neuropharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImpel Neuropharma Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A